Literature DB >> 26577107

Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

T T Zhang1, X Q Zhao2, Z Liu2, Z Y Mao3, L Bai4.   

Abstract

OBJECTIVE: Indications for resection of hepatocellular carcinoma (HCC) remain controversial. This study aimed to identify prognostic factors that affect overall survival (OS) and disease-free survival (DFS) in patients with HCC after hepatectomy.
METHODS: From 2004 to 2010, 601 patients with HCC who underwent resection were enrolled. Factors stratified into the host, biochemical, surgical treatment and tumor-related features in terms of recurrence and overall survival were analyzed. Prognostic factors were evaluated by univariate and multivariate analyses, with Kaplan-Meier survival analyses and Cox proportional hazard model.
RESULTS: The overall survival rates of 1-, 3- and 5- year were 79, 62, and 54 %, and the corresponding DFS rates were 51, 38 and 31 %, respectively. In a multivariate analysis, Child-Pugh, serum AFP level, ALT level, time for hepatic resection, tumor differentiation, maximum size of tumors, local necrosis, portal vein tumor thrombus, and TNM Stage were correlated significantly with patients' OS. Gender (P = 0.046), cigarette smoking (P = 0.007), serum AFP level (P = 0.001), GGT level (P = 0.002), maximum size of tumors (P = 0.009), liver cirrhosis (P = 0.025), portal vein tumor thrombus (P = 0.022), microvascular tumor thrombus (P = 0.007) and TNM Stage (P = 0.001) were significantly affected DFS.
CONCLUSION: Preoperative AFP level, maximum size of tumors, portal vein tumor thrombus and TNM Stage were revealed as important prognostic factors for OS and DFS through follow-up of a relatively large cohort of Chinese HCC patients.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Patient prognosis

Mesh:

Year:  2015        PMID: 26577107     DOI: 10.1007/s12094-015-1446-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Outcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter).

Authors:  Yo-ichi Yamashita; Akinobu Taketomi; Ken Shirabe; Shinichi Aishima; Eiji Tsuijita; Kazutoyo Morita; Hiroto Kayashima; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2011-04-04       Impact factor: 3.454

3.  Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.

Authors:  S Eguchi; T Kanematsu; S Arii; M Omata; M Kudo; M Sakamoto; K Takayasu; M Makuuchi; Y Matsuyama; M Monden
Journal:  Br J Surg       Date:  2011-01-25       Impact factor: 6.939

4.  Influences of tobacco and alcohol use on hepatocellular carcinoma survival.

Authors:  Wei-Liang Shih; Hung-Chuen Chang; Yun-Fan Liaw; Shi-Ming Lin; Shou-Dong Lee; Pei-Jer Chen; Chun-Jen Liu; Chih-Lin Lin; Ming-Whei Yu
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

5.  Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.

Authors:  Toshiya Ochiai; Hisashi Ikoma; Kazuma Okamoto; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

6.  Smoking and risk of total and fatal prostate cancer in United States health professionals.

Authors:  E Giovannucci; E B Rimm; A Ascherio; G A Colditz; D Spiegelman; M J Stampfer; W C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-04       Impact factor: 4.254

7.  Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; A-Hon Kwon; Yasuo Kamiyama
Journal:  Am J Surg       Date:  2009-01-29       Impact factor: 2.565

8.  A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma.

Authors:  Lei Hu; Feng Xue; Yunyun Li; Minhua Shao; Yanfu Sun; Gongtian Wei
Journal:  Cell Biochem Biophys       Date:  2014-07       Impact factor: 2.194

9.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

Review 10.  Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Yan-Gang Wang; Peng Wang; Bin Wang; Zheng-Ju Fu; Wen-Juan Zhao; Sheng-Li Yan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more
  10 in total

1.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

2.  Prognostic value of preoperative peripheral monocyte count in patients with hepatocellular carcinoma after liver transplantation.

Authors:  Qing-Qi Ren; Shun-Jun Fu; Qiang Zhao; Zhi-Yong Guo; Fei Ji; Mao-Gen Chen; Lin-Wei Wu; Xiao-Shun He
Journal:  Tumour Biol       Date:  2016-01-12

3.  Identification of Hub Genes Associated With Hepatocellular Carcinoma Using Robust Rank Aggregation Combined With Weighted Gene Co-expression Network Analysis.

Authors:  Hao Song; Na Ding; Shang Li; Jianlong Liao; Aimin Xie; Youtao Yu; Chunlong Zhang; Caifang Ni
Journal:  Front Genet       Date:  2020-09-30       Impact factor: 4.599

4.  The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.

Authors:  Dou-Sheng Bai; Chi Zhang; Ping Chen; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

5.  Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.

Authors:  Ping Sun; Yanlong Li; Lijun Chang; Xudong Tian
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  GNAO1 as a Novel Predictive Biomarker for Late Relapse in Hepatocellular Carcinoma.

Authors:  Meiling Du; Jie Feng; Yiran Tao; Qincong Pan; Fengyuan Chen
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

7.  Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.

Authors:  Wuzheng Xia; Tianyi Peng; Renguo Guan; Yu Zhou; Cong Zeng; Ye Lin; Zhongshi Wu; Hongmei Tan
Journal:  Ann Transl Med       Date:  2021-10

8.  Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis.

Authors:  Zhao-Ru Dong; Jie Zou; Dong Sun; Guo-Ming Shi; Ai-Wu Ke; Jia-Bin Cai; Hui-Chuan Sun; Shuang-Jian Qiu; Tao Li; Jian Zhou; Xu-Ting Zhi; Jia Fan
Journal:  J Cancer       Date:  2017-10-17       Impact factor: 4.207

9.  The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.

Authors:  Yang Ou; Junwei Huang; Liping Yang
Journal:  Biosci Rep       Date:  2018-11-28       Impact factor: 3.840

10.  Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy.

Authors:  Ya-Li Tian; Jing-Jing Ji; Lu-Ning Chen; Xin-Long Cui; Shi-Teng Liu; Liang Mao; Yu-Dong Qiu; Bing-Bing Li
Journal:  World J Clin Cases       Date:  2020-02-26       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.